Communications
Table 2: Nucleophilic fluorinations of the various substrates.
hexane (22 mL). The mixture was stirred for 30 min at 908C. During
this time TBAF dissolved completely. The solution was cooled to
room temperature, and a white crystalline solid precipitated. The
crystalline solid was filtered and washed rapidly with 40 mL of 70%
tBuOH/hexane. The filtrate was kept in vacuum for 15–20 min to
[
a]
[b]
Entry Substrate
Method
Yield [%]
product alkene alcohol
[
c]
1
2
3
4
A
B
C
D
71
9
33
88
29
91
61
10
–
–
5
–
remove residual solvent, and TBAF(tBuOH) (1, 1.63 g, 2.92 mmol)
4
1
was obtained as white crystalline solid in 92% yield. H NMR
(600 MHz, CDCl ): d = 1.01 (t, J = 9.0 Hz, 12H), 1.27 (s, 36H), 1.42–
3
1
.48 (m, 8H), 1.66–1.71 (m, 8H), 3.44 ppm (t, J = 9.0 Hz, 8H);
5
6
7
A
B
C
80
22
63
19
78
30
–
–
6
1
3
C NMR (150 MHz, CDCl ): d = 13.6, 19.6, 24.0, 31.1, 58.5, 68.2 ppm.
3
Typical procedure for fluorination (Table 1, entry 1, or Method A
in Table 2): 1 (1.1 g, 2 mmol) was added to a solution of mesylate 2
280 mg, 1.0 mmol) in CH CN (4.0 mL). The mixture was stirred for
(
3
[
d]
d]
8
A
A
A
98
93
–
–
–
–
–
1.0 h at 708C. The residue was dissolved in water (6.0 mL) and
extracted from the aqueous phase with diethyl ether (6.0 mL ꢁ 3). The
organic layer was dried (sodium sulfate) and evaporated under
reduced pressure. The residue was purified by short flash column
chromatography (5% EtOAC/hexane) to give 2-(3-fluoropropoxy)-
[
9
–
1
naphthalene (3a, 200 mg, 98%) as a colorless oil. H NMR (400 MHz,
CDCl ): d = 2.14–2.39 (m, 2H), 4.24 (t, J = 6.2 Hz, 2H), 4.72 (dt, J =
3
46.8, 5.8 Hz, 2H), 7.16–7.22 (m, 2H), 7.34–7.53 (m, 2H), 7.76–
1
3
7.83 ppm (m, 3H); C NMR (100 MHz, CDCl ): d = 30.4 (d, J =
3
2
1
2
0.1 Hz), 63.6 (d, J = 5.3 Hz), 80.8 (d, J = 163.9 Hz), 106.8, 118.8,
1
0
100
23.6, 126.4, 126.7, 127.6, 129.1, 129.4, 134.6, 156.7 ppm; MS (EI) m/z
+
+
04 [M ]; HRMS (EI) m/z calcd for C H FO [M ] 204.0950, found
13 13
[a] Method A: reactions were carried out on a 1.0 mmol scale of substrate with
204.0932.
2
.0 equiv of TBAF(tBuOH) at 708C for 1 h in 4.0 mL of CH CN; B: from the
4
3
protocol of reference [7a]; the reaction was carried out using 0.2 mmol scale
Received: July 1, 2008
Published online: September 29, 2008
of the substrate with 2.0 equiv of TBAFanh generated in situ in CD CN at 258C;
3
C: TBAF was used; D: TBAF(tBuOH)4 in tBuOH. [b] Yield determined by
1
H NMR spectroscopy. [c] Desired fluoro product. [d] Yield of isolated
Keywords: alcohols · fluorination · fluorine ·
product. [e] TBDMS=tert-butyldimethylsilyl, Ts=4-toluenesulfonyl.
.
nucleophilic substitution · tetrabutylammonium fluoride
TBAF. The displacement of a benzylic bromide using TBAF-
[
(
tBuOH) proceeds smoothly with nearly complete conver-
4
sion to the fluoride (Table 2, entry 8). A fluoro-flumazenile,
[
10]
Mascaretti, Aldrichimica Acta 1993, 26, 47 – 58.
[3] a) G. W. Gokel, Crown Ethers and Cryptands, Royal Society of
Chemistry, Cambridge, 1991; b) E. V. Dehmlow, S. S. Dehmlow,
which can be a molecular probe for PET, was produced in
3% yield by reaction with the corresponding tosylate
9
precursor (Table 2, entry 9). In the final example, the
desilylation reaction at 708C using TBAF(tBuOH)4 pro-
ceeded quantitatively within 30 min (Table 2, entry 10).
In summary, we report tetrabutylammonium tetra(tert-
[
butyl alcohol) coordinated fluoride, TBAF(tBuOH) , as a
4
highly effective nucleophilic fluorination reagent along with
its characteristics. TBAF(tBuOH)4 has various favorable
properties, such as a unique and stable structure surrounded
by four bulky nonpolar protic tert-butyl alcohol molecules (a
[
[
“
flexible” fluoride form), a dehydrated state for anhydrous
reaction conditions, low hygroscopicity, and good nucleophi-
licity with low basicity. These favorable properties not only
suppress the side reactions (hydroxylation, alkoxylation, and
elimination) in the fluorination reaction but also allow easy
handling. Further studies on the development of a more
efficient protocol with an alcohol coordinated fluoride species
[
1
8
and the application of F labeling for radiopharmaceuticals
for PET are currently underway.
[9] For a comparison of TBAF(tBuOH) and TBAF for fluorination
4
in tBuOH, see Table 8S in the Supporting Information.
10] M. Mitterhauser, W. Wadsak, L. Wabnegger, L. K. Mien, S.
[
Experimental Section
Preparation of TBAF(tBuOH) : Commercially available TBAF
4
hydrate (1.0 g, 3.17 mmol) was added to tBuOH (88 mL) and n-
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2008, 47, 8404 –8406